Muscular Dystrophy News3 小时
ENTR-601-44 trial for DMD adults amenable to exon 44 skipping OK’d
The FDA has lifted its hold and has given Entrada Therapeutics permission to launch a Phase 1b clinical trial to test ...
H.C. Wainwright维持Entrada股票买入评级，目标价20美元
周二，H.C. Wainwright维持对Entrada Therapeutics股票的买入评级，目标价为USD 20.00。这家市值4.76亿美元的生物科技公司目前市盈率为12.79，估值具有吸引力，并且收到了重要的监管消息。该公司分析师Boobalan ...
ENDPOINTS NEWS22 小时
FDA lifts hold on En­trada's Duchenne drug af­ter two years
Phase 1b US study planned for 2026, as company competes with NS Pharma and Avidity Biosciences in exon 44 space ...
www.cs.cmu.edu20 小时
Introduction to Machine Learning
Q: How does 10-301 differ from 10-601? A: Undergraduates must register for 10-301 and graduate students must register for 10-601. Otherwise, the courses will be identical in all respects. A: This is ...